Economic upturn but increasing central government debt
June 16, 2004 03:30 ET
|
Riksgälden
This improvement is due to increasing tax revenue ensuing from a cyclical upswing and to lower interest payments on central government debt. The reduction in interest payments - from SEK 49 billion in...
Aandeelhouders keuren jaarrekening goed en verlenen decharge
June 16, 2004 03:28 ET
|
GeoJunxion N.V.
De aandeelhouders van AND hebben op de gisteren gehouden jaarvergadering de jaarrekening over 2003 goedgekeurd en decharge verleend aan de raad van bestuur en raad van...
Skanska to Build Hospital in Florida for SEK 608 M (USD 80 M)
June 16, 2004 03:20 ET
|
Skanska
STOCKHOLM, Sweden, June 16, 2004 (PRIMEZONE) -- Skanska has been awarded the construction assignment to build a new hospital that will replace the existing facility at the Homestead Hospital in...
OMHEX sells XACT Fonder to Svenska Handelsbanken
June 16, 2004 03:13 ET
|
OMX
STOCKHOLM, Sweden, June 16, 2004 (PRIMEZONE) -- As part of OMHEX's continued focus on core operations, OMHEX has signed an agreement with Svenska Handelsbanken to sell XACT Fonder AB to...
Ainax -- Notice of Extraordinary General Meeting
June 16, 2004 03:09 ET
|
Ainax
STOCKHOLM, Sweden, June 16, 2004 (PRIMEZONE) -- The shareholders of Ainax AB (publ) (the "company") are hereby convened to an extraordinary general meeting of shareholders on Thursday 1 July 2004, at...
Volvo -- Truck deliveries January-May 2004
June 16, 2004 02:37 ET
|
Volvo
GOTEBORG, Sweden, June 16, 2004 (PRIMEZONE) -- Total deliveries of trucks from the Volvo Group's three truck companies increased 20% through May this year, compared with the year-earlier period....
Outcome of Framfab's Rights Issue
June 16, 2004 02:14 ET
|
Framfab
STOCKHOLM, Sweden, June 16, 2004 (PRIMEZONE) -- Framfab AB's (publ) new share issue, which has been fully subscribed and provides the company with SEK 164 million prior to transaction costs, was...
Additional FDA Fast Track Designation for Basilea's Novel First-In-Class Antibiotic
June 16, 2004 01:31 ET
|
Basilea Pharmaceutica Ltd
BASEL, Switzerland, June 16, 2004 (PRIMEZONE) -- Basilea Pharmaceutica AG announced today that it received a second fast track designation from the U.S. Food and Drug Administration (FDA) for its...
Actelion Ltd. -- Extended License Agreement for Zavesca
June 16, 2004 01:23 ET
|
Actelion Ltd.
ALLSCHWIL/BASEL, SWITZERLAND and SLOUGH, U.K., June 16, 2004 (PRIMEZONE) -- Actelion Ltd. (SWX:ATLN):
-- Actelion and Celltech extend Zavesca(r) license agreement
-- Celltech grants...
Additional FDA Fast Track Designation for Basilea's Novel First-In-Class Antibiotic
June 16, 2004 01:15 ET
|
Basilea Pharmaceutica AG
Basel, Switzerland, 16 June 2004
Basilea Pharmaceutica AG announced today that it received a second fast track designation from the U.S. Food and Drug Administration (FDA) for its novel...
- July 28, 2024 16:51 ET Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer’s Disease at the Alzheimer’s Association International Conference® (AAIC)
- July 26, 2024 17:00 ET Premier American Uranium Outlines Multiple Targets for Expansion Drilling at the Cebolleta Project, New Mexico